Concepedia

Marcus Saarinen

MS

Statistics

Publications

5

Citations

179

H-Index

5

Active since

2018

Affiliations

Karolinska Institutet(Current)

Science for Life Laboratory

King's College London

Umeå University

Uppsala University

Marcus Saarinen is an author at Karolinska Institutet specializing in pharmacology, ligand binding, and neuropharmacology.

ORCID

Publications per year

2018–2024

5

Publications

5

Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson’s Disease

Mariama Jaiteh, Alexey A. Zeifman, Marcus Saarinen et al. · Journal of Medicinal Chemistry · 2018 · 56 citations · Full text

, , +17

AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1

Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo et al. · Science Advances · 2024 · 51 citations · Full text

, , +15

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-363856

Marcus Saarinen, Ioannis Mantas, Ivana Flais et al. · Neuropsychopharmacology · 2022 · 33 citations · Full text

, , +17

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics

Richard Ågren, Nibal Betari, Marcus Saarinen et al. · The International Journal of Neuropsychopharmacology · 2023 · 22 citations · Full text

, , +16

Claustrum and dorsal endopiriform cortex complex cell-identity is determined by Nurr1 and regulates hallucinogenic-like states in mice

Ioannis Mantas, Ivana Flais, Yuvarani Masarapu et al. · Nature Communications · 2024 · 17 citations · Full text

, , +10

1–5 of 5